Praxis precision medicines to announce third quarter 2024 financial results and host conference call on wednesday, november 6, 2024

Boston, nov. 01, 2024 (globe newswire) -- praxis precision medicines , inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced it will report its financial results from the third quarter ended september 30, 2024, before the financial markets open on wednesday, november 6, 2024.
PRAX Ratings Summary
PRAX Quant Ranking